Anson Funds Management LP - 31 Mar 2025 SCHEDULE 13G Report for NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP)

Filing Manager: Anson Funds Management LP
Reporting Manager: Anson Funds Management LP
Security: NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: NRXP
Shares outstanding: 16,843,729 shares
Disclosed Ownership: 1,179,061 shares
Ownership: 7%
Form type: SCHEDULE 13G
Filing time: 15 May 2025, 17:15:19 UTC
Date of event: 31 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Quoteable Key Fact

"Anson Funds Management LP disclosed 7% ownership in NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP) on 31 Mar 2025."

Quick Takeaways

Anson Funds Management LP filed SCHEDULE 13G for NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP).
Disclosed ownership: 7%.
Date of event: 31 Mar 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Anson Funds Management LP	7%	1,179,061	1,179,061	/s/ Tony Moore	Tony Moore, Manager
Anson Management GP LLC	7%	1,179,061	1,179,061	/s/ Tony Moore	Tony Moore, Manager
Tony Moore	7%	1,179,061	1,179,061	/s/ Tony Moore	Tony Moore, Manager
Anson Advisors Inc.	7%	1,179,061	1,179,061	/s/ Amin Nathoo	Amin Nathoo, Director
Amin Nathoo	7%	1,179,061	1,179,061	/s/ Amin Nathoo	Amin Nathoo, Director
Moez Kassam	7%	1,179,061	1,179,061	/s/ Moez Kassam	Moez Kassam, Director